1,5-anhydroglucitol monitoring in diabetes: A mass balance perspective

被引:14
|
作者
Nerby, Craig L. [1 ]
Stickle, Douglas F. [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA
关键词
1,5-anhydroglucitol; Diabetes; ORAL GLUCOSE-TOLERANCE; TERM GLYCEMIC CONTROL; CHRONIC-RENAL-FAILURE; SERUM 1,5-ANHYDROGLUCITOL; PLASMA 1,5-ANHYDRO-D-GLUCITOL; CEREBROSPINAL-FLUID; URINARY-EXCRETION; CLINICAL MARKER; MELLITUS; EXCURSIONS;
D O I
10.1016/j.clinbiochem.2008.08.086
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
1,5-anhydroglucitol (AG) is a nonmetabolizable glucose analogue found in plasma due to ingestion. The normal steady-state concentration can be dramatically decreased by inhibition of tubular reabsorption during periods of hyperglycemia. For this reason, monitoring of AG has been plausibly advocated for detection of periodic glucosuric hyperglycemia. In this review, we examine the influence of variation in factors affecting both steady-state and transient changes in plasma AG. Among normals, the lower and upper limits of the plasma AG reference range vary by a factor of 5. Using a simplified mass balance model (a single compartment model with 3-6x larger-than-plasma volume of distribution), reasonable inter-individual variations of ingestion rate, glomerular filtration rate and fractional post-filtration reabsorption are each able to account for the wide range of normal, steady-state AG concentrations. In monitoring of changes in AG, inter-individual variations in the threshold for glucose excretion, volume of distribution and glomerular filtration rate are all likely to significantly affect correspondence of integral changes in AG to integral glucosuria/ hyperglycemia. This combination of variables, affecting both steady-state and transient changes, is significantly confounding with respect to interpretation of serial plasma AG concentrations. Resolution of information content of AG monitoring is thus largely that of crossing simple characterization of deltas [+,0,-] for changes in AG concentration against the information content of hemoglobin Alc monitoring. Despite this limitation, AG monitoring can in principle provide information about glycemic control in the short term that is not apparent through monitoring of hemoglobin Alc alone. However, whether AG monitoring can lead to improved outcomes in diabetes management remains to be established. (C) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 50 条
  • [21] Escherichia coli phosphorylates 1,5-anhydroglucitol and releases 1,5-anhydroglucitol 6-phosphate when glucose is absent in the medium
    Shiga, Y
    Kametani, S
    Mizuno, H
    Akanuma, H
    JOURNAL OF BIOCHEMISTRY, 1996, 119 (01): : 173 - 179
  • [22] Saliva 1,5-Anhydroglucitol Detected by Liquid Chromatography-Mass Spectrometry Is a New Marker for Diabetes Screening
    Bao, Yuqian
    Jian, Chaohui
    Zhao, Aihua
    Ma, Xiaojing
    Ge, Kun
    Lu, Wei
    Zhu, Wei
    Wang, Yufei
    Zhou, Jian
    Jia, Wei
    DIABETES, 2020, 69
  • [23] Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
    Malkan, Umit Yavuz
    Gunes, Gursel
    Corakci, Ahmet
    SPRINGERPLUS, 2015, 4
  • [24] Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
    Selvin, Elizabeth
    Rawlings, Andreea
    Lutsey, Pamela
    Maruthur, Nisa
    Pankow, James S.
    Steffes, Michael
    Coresh, Josef
    DIABETES, 2016, 65 (01) : 201 - 208
  • [25] Serum 1,5-anhydroglucitol is low in gastrectomized men
    Murai, Jun
    Koga, Masafumi
    Saito, Hiroshi
    Mukai, Mikio
    Kasayama, Soji
    ACTA DIABETOLOGICA, 2014, 51 (02) : 337 - 338
  • [26] 1,5-Anhydroglucitol analysis by tandem mass spectrometry: A method for clinical application
    Burton, T. R.
    Parry, D. M.
    Seargeant, L. E.
    Mallory, C.
    Helewa, M.
    Sokoro, A. A. H.
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : 1167 - 1168
  • [27] Circulating 1,5-Anhydroglucitol as a Biomarker of ss-cell Mass Independent of a Diabetes Phenotype in Human Subjects
    Jimenez-Sanchez, Cecilia
    Mezza, Teresa
    Sinturel, Flore
    Li, Lingzi
    Di Giuseppe, Gianfranco
    Quero, Giuseppe
    Jornayvaz, Francois R.
    Guessous, Idris
    Dibner, Charna
    Schrauwen, Patrick
    Alfieri, Sergio
    Giaccari, Andrea
    Maechler, Pierre
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (10): : 2833 - 2843
  • [28] Comparison of Two Assays for Serum 1,5-Anhydroglucitol
    Selvin, Elizabeth
    Rynders, Gregory P.
    Steffes, Michael W.
    CLINICA CHIMICA ACTA, 2011, 412 (9-10) : 793 - 795
  • [29] FEEDING AND HYPERGLYCEMIA INDUCED BY 1,5-ANHYDROGLUCITOL IN THE RAT
    SAKATA, T
    TSUTSUI, K
    FUKUSHIMA, M
    ARASE, K
    KITA, H
    OOMURA, Y
    PHYSIOLOGY & BEHAVIOR, 1981, 27 (03) : 401 - 405
  • [30] Serum 1,5-anhydroglucitol is low in gastrectomized men
    Jun Murai
    Masafumi Koga
    Hiroshi Saito
    Mikio Mukai
    Soji Kasayama
    Acta Diabetologica, 2014, 51 : 337 - 338